Mono Pharmacare Limited (NSE:MONOPHARMA)

Mono Pharmacare Statistics

Total Valuation

Mono Pharmacare has a market cap or net worth of INR 301.25 million. The enterprise value is 839.18 million.

Market Cap	301.25M
Enterprise Value	839.18M

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Mono Pharmacare has 17.67 million shares outstanding. The number of shares has increased by 7.91% in one year.

Current Share Class	17.67M
Shares Outstanding	17.67M
Shares Change (YoY)	+7.91%
Shares Change (QoQ)	+15.82%
Owned by Insiders (%)	56.72%
Owned by Institutions (%)	n/a
Float	7.65M

Valuation Ratios

The trailing PE ratio is 39.20.

PE Ratio	39.20
Forward PE	n/a
PS Ratio	0.20
PB Ratio	0.96
P/TBV Ratio	0.97
P/FCF Ratio	51.36
P/OCF Ratio	44.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.34, with an EV/FCF ratio of 143.08.

EV / Earnings	100.71
EV / Sales	0.57
EV / EBITDA	17.34
EV / EBIT	17.79
EV / FCF	143.08

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 1.76.

Current Ratio	1.92
Quick Ratio	1.01
Debt / Equity	1.76
Debt / EBITDA	11.37
Debt / FCF	93.77
Interest Coverage	1.31

Financial Efficiency

Return on equity (ROE) is 2.73% and return on invested capital (ROIC) is 3.56%.

Return on Equity (ROE)	2.73%
Return on Assets (ROA)	2.69%
Return on Invested Capital (ROIC)	3.56%
Return on Capital Employed (ROCE)	8.16%
Revenue Per Employee	12.83M
Profits Per Employee	72,461
Employee Count	115
Asset Turnover	1.35
Inventory Turnover	2.71

Taxes

In the past 12 months, Mono Pharmacare has paid 5.89 million in taxes.

Income Tax	5.89M
Effective Tax Rate	41.15%

Stock Price Statistics

The stock price has decreased by -52.77% in the last 52 weeks. The beta is -1.91, so Mono Pharmacare's price volatility has been lower than the market average.

Beta (5Y)	-1.91
52-Week Price Change	-52.77%
50-Day Moving Average	21.67
200-Day Moving Average	26.46
Relative Strength Index (RSI)	32.67
Average Volume (20 Days)	11,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mono Pharmacare had revenue of INR 1.48 billion and earned 8.33 million in profits. Earnings per share was 0.43.

Revenue	1.48B
Gross Profit	127.70M
Operating Income	47.16M
Pretax Income	14.32M
Net Income	8.33M
EBITDA	48.39M
EBIT	47.16M
Earnings Per Share (EPS)	0.43

Balance Sheet

The company has 12.40 million in cash and 549.96 million in debt, giving a net cash position of -537.56 million or -30.42 per share.

Cash & Cash Equivalents	12.40M
Total Debt	549.96M
Net Cash	-537.56M
Net Cash Per Share	-30.42
Equity (Book Value)	312.56M
Book Value Per Share	15.23
Working Capital	567.79M

Cash Flow

In the last 12 months, operating cash flow was 6.79 million and capital expenditures -924,000, giving a free cash flow of 5.87 million.

Operating Cash Flow	6.79M
Capital Expenditures	-924,000
Free Cash Flow	5.87M
FCF Per Share	0.33

Margins

Gross margin is 8.65%, with operating and profit margins of 3.20% and 0.56%.

Gross Margin	8.65%
Operating Margin	3.20%
Pretax Margin	0.97%
Profit Margin	0.56%
EBITDA Margin	3.28%
EBIT Margin	3.20%
FCF Margin	0.40%

Dividends & Yields

Mono Pharmacare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.91%
Shareholder Yield	-7.91%
Earnings Yield	2.77%
FCF Yield	1.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3